Eve review

Eve for moms: our verdict

One flat $195 price for either compounded medication, with a needle-free sublingual option and brand-name access on the same platform — but the real price only shows up once you're inside the signup flow, not on the public page. The advertised starting price is $99, but the regular rate settles nearer $195/mo — so read the headline as an intro offer, not as the monthly cost.

We looked at Eve the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Eve actually costs

• Compounded semaglutide — Compounded injection: $99 to start, then $195/mo
• Compounded tirzepatide — Compounded injection: $99 to start, then $195/mo
• Oral semaglutide — Sublingual (oral): $195/mo
• Brand-name semaglutide — Ozempic (brand-name): $1399/mo
• Brand-name semaglutide — Wegovy (brand-name): $1699/mo
• Brand-name tirzepatide — Mounjaro (brand-name): $1399/mo

That's roughly in line with our list's median of ~$179/mo.

Eve prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

That price covers the consult, the medication and shipping.

The medications Eve prescribes

Eve lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. It can point you toward FDA-approved brand-name medications as well as the compounded versions — approved products carry the manufacturer's own pregnancy and breastfeeding label, which is cleaner to hand to an OB-GYN.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. Eve lists its coverage as: Multiple states (not fully listed — confirm yours before signing up).

Where Eve fits — and where it doesn't — for moms

A good fit if…

• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Before choosing Eve, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Eve is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.